These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 6364159)
1. The role of chloramphenicol in pediatric therapy. Kauffman RE Prog Clin Biol Res; 1983; 135():315-27. PubMed ID: 6364159 [No Abstract] [Full Text] [Related]
2. Pediatric antimicrobial therapy I. Marks MI; Shapera RM; Brazeau M Can Med Assoc J; 1973 Jul; 109(1):49-50. PubMed ID: 4717089 [No Abstract] [Full Text] [Related]
3. Chloramphenicol: clinical pharmacology in pediatrics. Ristuccia AM Ther Drug Monit; 1985; 7(2):159-67. PubMed ID: 3895607 [No Abstract] [Full Text] [Related]
4. [15 years of clinical experience with chloramphenicol in pediatrics]. Martoni L; Mei V Minerva Pediatr; 1971 May; 23(21):935-42. PubMed ID: 5093896 [No Abstract] [Full Text] [Related]
5. Twenty years of chloramphenicol therapy in paediatrics. Szórády I Ther Hung; 1973; 21(1):3-9. PubMed ID: 4600847 [No Abstract] [Full Text] [Related]
6. The current status of chloramphenicol. Meissner HC; Smith AL Pediatrics; 1979 Sep; 64(3):348-56. PubMed ID: 384354 [No Abstract] [Full Text] [Related]
7. [Need for limitation and rational administration of chloramphenicol-containing drugs]. Pstragowska W Pediatr Pol; 1973 Aug; 48(8):1033-9. PubMed ID: 4585106 [No Abstract] [Full Text] [Related]
8. [Experiences with ciclacillin in pediatric practice]. Krauthammer W MMW Munch Med Wochenschr; 1975 Sep; 117(36):1435-6. PubMed ID: 809689 [No Abstract] [Full Text] [Related]
9. [Changes in serum immunoglobulin levels in the chloramphenicol therapy of children]. Polívka V; Machálek J Cesk Pediatr; 1977 Jan; 32(1):28-9. PubMed ID: 844125 [No Abstract] [Full Text] [Related]
10. The benefits of drug monitoring in patients with bacterial meningitis, eg, chloramphenicol monitoring. Rosin H; Crea A; Forster J Pediatr Pharmacol (New York); 1983; 3(3-4):175-80. PubMed ID: 6377214 [TBL] [Abstract][Full Text] [Related]
12. Broader picture surrounding new pediatric labeling for topical corticosteroid therapy. D'Alonzo GE J Am Osteopath Assoc; 1999 Jan; 99(1):15-6, 18. PubMed ID: 9972090 [No Abstract] [Full Text] [Related]
13. Chloramphenicol in the 1980s. Shalit I; Marks MI Drugs; 1984 Oct; 28(4):281-91. PubMed ID: 6386425 [No Abstract] [Full Text] [Related]
14. Current challenges in pediatric drug development. Adamson PC Clin Adv Hematol Oncol; 2008 Dec; 6(12):883-4. PubMed ID: 19209138 [No Abstract] [Full Text] [Related]
15. [CAF today. Clinical considerations on its possible usefulness in pediatrics (author's transl)]. Nigro N Minerva Pediatr; 1980 Aug; 32(16):1007-9. PubMed ID: 7453680 [No Abstract] [Full Text] [Related]
16. An audit of chloramphenicol use in a large community hospital. Feder HM; Osier C; Maderazo EG Arch Intern Med; 1981 Apr; 141(5):597-8. PubMed ID: 6894362 [TBL] [Abstract][Full Text] [Related]
17. Drug development in pediatrics: problems and strategies. The point of view of the academic community. Soyka LF Pediatr Pharmacol (New York); 1980; 1(1):21-4. PubMed ID: 7346728 [No Abstract] [Full Text] [Related]
18. FDA notifications. FDA approves pediatric efficacy supplement for didanosine capsules. AIDS Alert; 2008 Nov; 23(11):129. PubMed ID: 19043871 [No Abstract] [Full Text] [Related]